[Other] 1247-OR: Evolocumab Reduces CV Events in Patients with High-Risk Diabetes: Results from the VESALIUS-CV Trial |
|
This post will be closed automatically in 2026-10-20 12:40
Reward20points
|
post
reply
points
20
30
The honey bee stinger: An unusual pump with collapsible double pistons
20
The Contingent Effects of IS Certifications on the Trustworthiness of Websites
10
Extreme greenhouse warmth triggered the two major floristic turnover events of the past 120 million years
40
The central melanocortin system regulates growth hormone secretion
20
1247-OR: Evolocumab Reduces CV Events in Patients with High-Risk Diabetes: Results from the VESALIUS-CV Trial
